title: Permeation Studies of Captopril Transdermal Films Through Human Cadaver Skin.
abstract: Mortality rate due to heart diseases increases dramatically with age. Captopril is an angiotensin converting enzyme inhibitor (ACE) used effectively for the management of hypertension. Due to short elimination half-life of captopril the oral dose is very high. Captopril is prone to oxidation and it has been reported that the oxidation rate of captopril in skin tissues is considerably low when compared to intestinal tissues. All these factors make captopril an ideal drug candidate for transdermal delivery. In this research work an effort was made to formulate transdermal films of captopril by utilizing polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA) as film formers and polyethylene glycol 400 (PEG400) as a plasticizer. Dimethyl sulfoxide (DMSO) and dimethylformamide (DMF) were used as permeation enhancers. Physicochemical parameters of the films such as appearance, thickness, weight variation and drug content were evaluated. The invitro permeation studies were carried out through excised human cadaver skin using Franz diffusion cells. The in-vitro permeation studies demonstrated that the film (P4) having the polymer ratio (PVP:PVA = 80:20) with DMSO (10%) resulted a promising drug release of 79.58% at 24 hours with a flux of 70.0 µg/cm(2)/hr. No signs of erythema or oedema were observed on the rabbit skin as a result of skin irritation study by Draize test. Based on the stability report it was confirmed that the films were physically and chemically stable, hence the prepared films are very well suited for transdermal application.
authors: Faculty of Pharmaceutical Sciences, UCSI University, No.1, Jalan Menara Gading, UCSI Heights, Cheras 56000, Kuala Lumpur, Malaysia. raajsnair@yahoo.co.in.
authors: Rajesh Sreedharan
authors: RS
authors: Nair
authors: Sujith
authors: S
authors: Nair
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D002102:Cadaver; D002216:Captopril / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D004121:Dimethyl Sulfoxide / Q000737:chemistry / Q000494:pharmacology; D004126:Dimethylformamide / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D010084:Oxidation-Reduction; D010539:Permeability / Q000187:drug effects; D011092:Polyethylene Glycols / Q000737:chemistry; D011142:Polyvinyl Alcohol / Q000737:chemistry; D011205:Povidone / Q000737:chemistry; D011817:Rabbits; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D012869:Skin Absorption / Q000187:drug effects; D057968:Transdermal Patch
chemical_list: D011092:Polyethylene Glycols; D004126:Dimethylformamide; D011142:Polyvinyl Alcohol; D002216:Captopril; C000595213:polyethylene glycol 400; D011205:Povidone; D004121:Dimethyl Sulfoxide